Thrombo-embolic and bleeding complications in patients with mechanical valve replacements - A prospective observational study

South African Medical Journal

Volumn 96, Issue 8, 2006, Pages 710-713

  Schapkaitz, E ^a   Jacobson, B F ^a   Becker, P ^b   Conway, G ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GENERAL HOSPITAL; HEALTH CARE FACILITY; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MITRAL VALVE REPLACEMENT; OBSERVATIONAL STUDY; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ADMINISTRATION, ORAL; ANTICOAGULANTS; AORTIC VALVE; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE; PROSPECTIVE STUDIES; SOUTH AFRICA; THROMBOEMBOLISM;

EID: 33748363714     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641.
2. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease: native and prosthetic; the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126: suppl, 457S-482S.
3. Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291-301.
4. Marcus RH, Sareli P, Pocock W, Barlow J. The spectrum of severe rheumatic mitral valve disease in a developing country. Ann Intern Med 1994; 120: 177-183.
5. Szekely P. Systemic embolization and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964; 1: 209-212.
6. Hirsch J, Deykin D, Poller L. Therapeutic range for anticoagulant therapy. Chest 1986; 89: suppl 2, 11S-15S.
7. Saour JN, Sieck JO, Mamo, LAR, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322: 428-432.
8. Hering D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude medical valve replacement. Chest 2005; 127: 53-59.
9. Pengo V, Barbero F, Banzato A, et al. A comparison of a moderate with moderate high intensity oral anticoagulant treatment in patients with mechanical valve prostheses. Thromb Haemost 1997; 77: 839-844.
10. Cannegieter SC, Rosendaal FR, Wintzen AR, Van Der Meer FJM, Vandanbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-17.
11. Buchanan-Lee B, Levetan B, Lombard CJ, Commerford PJ. Fixed- dose vs adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population. J Heart Valve Dis 2002; 11: 583-592.
12. Kornblit P, Senderoff J, Davis-Ericksen M, Zenk J. Anticoagulation therapy: patient management and evaluation of an outpatient clinic. Nurse Pract 1990; 15: 21-26.